AbstractHeart failure is one of the leading causes of mortality and morbidity in the world. Heart transplantation is still the gold standard therapy despite emerging treatment options. Due to the limited number of available donors, the use of ventricular assist devices has increased. However, increasing incidences of complications are observed with using these devices. In this article, surgical treatment of a huge mobile thrombus formation in an inflow cannula due to ineffective anticoagulation in a 59year-old man who received a HeartWare ventricular assist device because of ischemic cardiomyopathy is presented
Surgical therapy for the treatment of heart failure is a relatively young solution to a problem that...
Surgical therapy for the treatment of heart failure is a relatively young solution to a problem that...
AbstractBackground: Implantable left ventricular assist devices are common as a bridge to transplant...
AbstractHeart failure is one of the leading causes of mortality and morbidity in the world. Heart tr...
Pump thrombosis is a serious complication of continuous-flow left ventricular assist devices (LVAD)....
There are no reports of acute pump thrombosis in the latest, continuous flow left ventricular assis...
Heparin-induced thrombocytopenia is an immune-mediated serious adverse effect of heparin therapy. It...
line) infection, arrhythmias and pump thrombosis [4]. The incidence of pump thrombosis was reported ...
Acute myocardial infarction is a rare event in a patient with a left ventricular assist device (LVAD...
BackgroundThe HeartWare left ventricular assist device (HVAD, HeartWare Inc, Framingham, MA) is the ...
The clinical course of a patient with a left ventricular assist device is described. A total of 6 we...
Left ventricular assist device (LVAD) therapy remains a vital therapeutic option for patients with e...
PubMed ID: 23622612Background: In this report, we share our experience with left ventricular assist ...
The use of a left ventricular assist device has increased and is a primary surgical treatment for he...
In this article, we present our experience with left ventricular assist device implantation
Surgical therapy for the treatment of heart failure is a relatively young solution to a problem that...
Surgical therapy for the treatment of heart failure is a relatively young solution to a problem that...
AbstractBackground: Implantable left ventricular assist devices are common as a bridge to transplant...
AbstractHeart failure is one of the leading causes of mortality and morbidity in the world. Heart tr...
Pump thrombosis is a serious complication of continuous-flow left ventricular assist devices (LVAD)....
There are no reports of acute pump thrombosis in the latest, continuous flow left ventricular assis...
Heparin-induced thrombocytopenia is an immune-mediated serious adverse effect of heparin therapy. It...
line) infection, arrhythmias and pump thrombosis [4]. The incidence of pump thrombosis was reported ...
Acute myocardial infarction is a rare event in a patient with a left ventricular assist device (LVAD...
BackgroundThe HeartWare left ventricular assist device (HVAD, HeartWare Inc, Framingham, MA) is the ...
The clinical course of a patient with a left ventricular assist device is described. A total of 6 we...
Left ventricular assist device (LVAD) therapy remains a vital therapeutic option for patients with e...
PubMed ID: 23622612Background: In this report, we share our experience with left ventricular assist ...
The use of a left ventricular assist device has increased and is a primary surgical treatment for he...
In this article, we present our experience with left ventricular assist device implantation
Surgical therapy for the treatment of heart failure is a relatively young solution to a problem that...
Surgical therapy for the treatment of heart failure is a relatively young solution to a problem that...
AbstractBackground: Implantable left ventricular assist devices are common as a bridge to transplant...